MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has signed an agreement to acquire Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs)..

纽约州梅尔维尔（商业新闻短讯）--世界上最大的为办公室牙科医生和医生提供医疗保健解决方案的公司Henry Schein，Inc.（纳斯达克：HSIC）今天宣布，它已签署协议，收购Acentus，一家专门提供连续血糖监测仪（CGM）的国家医疗供应商。

The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic commitment to the homecare medical supplies market. Henry Schein’s homecare medical products platform will now have an annual revenue base of approximately $350 million..

继亨利·谢恩（HenrySchein）于2021年收购Prism Medical Products，LLC，并于2023年收购Shield Healthcare and Mini Pharmacy之后，Acentus的交易加强了该公司对家庭护理医疗用品市场的战略承诺。Henry Schein的家庭护理医疗产品平台现在的年收入基础约为3.5亿美元。

With annual revenue of approximately $35 million, Acentus is headquartered in Tampa, Florida. Henry Schein expects the transaction to be neutral to 2024 non-GAAP earnings per share and accretive thereafter. Closing is subject to standard closing conditions and is expected to be completed in the first quarter of 2025.

Acentus的年收入约为3500万美元，总部位于佛罗里达州坦帕。亨利·舍恩（Henry Schein）预计，该交易在2024年非公认会计准则每股收益之前将保持中性，此后将持续增长。交割以标准交割条件为准，预计于2025年第一季度完成。

Financial terms were not disclosed..

财务条款未披露。

“As the delivery of health care in the U.S. is increasingly provided in home-based settings, Henry Schein is strategically expanding our offerings to meet the growing demand,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. “We are pleased to announce our acquisition of Acentus, which enhances our ability to deliver CGM products directly to patients’ homes.

Henry Schein，Inc.董事会主席兼首席执行官斯坦利·伯格曼（Stanley M.Bergman）表示：“随着美国医疗保健服务越来越多地在家庭环境中提供，亨利·谢恩（Henry Schein）正在战略性地扩大我们的服务，以满足不断增长的需求。我们很高兴宣布收购Acentus，这增强了我们直接向患者家中提供CGM产品的能力。

With Acentus, we will strengthen our position nationally in the home medical supply market and better serve our valued customers, including clinics, physician practices, health systems, ambulatory surgery centers, and most importantly, patients and families.”.

有了Acentus，我们将加强我们在国内医疗供应市场的地位，更好地服务于我们的宝贵客户，包括诊所、医生诊所、卫生系统、门诊手术中心，最重要的是患者和家属。”

Upon closing, Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein and bring their expertise and experience in the product category and the health care industry.

交易结束后，Acentus创始人Brett Carroll、Todd Cianfrocca、Greg Duvall和Julio Valdivia将加入Henry Schein，带来他们在产品类别和医疗保健行业的专业知识和经验。

“We are delighted to partner with Henry Schein and further our efforts to provide accessible disposable medical supplies to the thousands of individuals nationwide who rely on these products to manage their chronic conditions,” said Mr. Cianfrocca, CEO of Acentus. “We are excited to contribute to the growth of Henry Schein’s emerging home health care business.”.

Acentus首席执行官Cianfrocca先生说：“我们很高兴与Henry Schein合作，并进一步努力为全国成千上万依靠这些产品来控制慢性病的人提供可获得的一次性医疗用品。”。“我们很高兴能为Henry Schein新兴的家庭医疗保健业务的发展做出贡献。”

Provident Healthcare Partners, LLC acted as the exclusive financial advisor to Acentus.

Provident Healthcare Partners，LLC担任Acentus的独家财务顾问。

About Henry Schein, Inc.

关于Henry Schein，Inc。

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.

Henry Schein，Inc.（纳斯达克股票代码：HSIC）是一家为医疗保健专业人士提供解决方案的公司，由人力和技术网络提供支持。该公司的可信顾问网络在全球拥有约26000名Schein团队成员，为全球100多万客户提供了300多个有价值的解决方案，有助于提高运营成功率和临床效果。

Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites..

我们的业务、临床、技术和供应链解决方案可帮助办公室牙科医生和医生更高效地工作，从而更有效地提供优质护理。这些解决方案还支持牙科实验室、政府和机构保健诊所以及其他替代保健场所。

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein private-brand products in stock.

Henry Schein通过一个集中和自动化的分销网络运营，库存有300000多种品牌产品和Henry Schein自有品牌产品。

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995..

亨利·谢恩是《财富》500强公司和标准普尔500指数的成员，总部位于纽约州梅尔维尔，在33个国家和地区设有业务或附属机构。2023年，该公司的销售额达到123亿美元，自1995年Henry Schein成为上市公司以来，年复合增长率约为11.5%。

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and @HenrySchein on X.

如需更多信息，请访问Henry Schein的网站www.henryschein.com、Facebook.com/henryschein、Instagram.com/HenryShein和@henryschein on X。

Cautionary Note Regarding Forward-Looking Statements

关于前瞻性声明的警示说明

In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein.

根据1995年《私人证券诉讼改革法案》的“安全港”规定，我们就可能导致未来结果与本文明示或暗示的前瞻性陈述、预期和假设产生重大差异的重要因素提供以下警示。

All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

我们所做的所有前瞻性陈述都存在风险和不确定性，并不能保证未来的表现。

These statements are generally identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make” or other comparable terms. A fuller discussion of our operations, financial condition, and status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange Commission, or SEC, including our Annual Report on Form 10-K, and will be contained in all subsequent periodic filings we make with the SEC.

这些陈述通常通过使用“可能”、“可能”、“预期”、“打算”、“相信”、“计划”、“估计”、“预测”、“项目”、“预期”、“未来”、“制造”或其他类似术语来识别。我们向美国证券交易委员会（SEC）提交的文件中包含了对我们的运营、财务状况和诉讼事项状况的更全面讨论，包括可能影响我们业务和未来前景的因素，包括我们在表格10-K中的年度报告，并将包含在我们随后向SEC提交的所有定期文件中。

These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations. Forward looking statements include the overall impact of the Novel Coronavirus Disease 2019 (COVID-19) on the Company, its results of operations, liquidity and financial condition (including any estimates of the impact on these items), the rate and consiste.

这些文件详细确定了可能导致我们的实际业绩与当前预期存在重大差异的重要风险因素。前瞻性陈述包括2019年新型冠状病毒病（COVID-19）对公司的总体影响，其运营结果，流动性和财务状况（包括对这些项目影响的任何估计），比率和一致性。

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: risks associated with COVID-19 and any variants thereof, as well as other disease outbreaks, epidemics, pandemics, or similar wide-spread public health concerns and other natural disasters; our dependence on third parties for the manufacture and supply of our products; our ability to develop or acquire and maintain and protect new products (particularly technology products) and technologies that achieve market acceptance with acceptable margins; transitional challenges associated with acquisitions, dispositions and joint ventures, including the failure to achieve anticipated synergies/benefits; legal, regulatory, compliance, cybersecurity, financial and tax risks associated with acquisitions, dispositions and joint ventures; certain provisions in our governing documents that may discourage third-party acquisitions of us; adverse changes in supplier rebates or other purchasing incentives; risks related to the sale of corporate brand products; effects of a highly competitive (including, without limitation, competition from third-party online commerce sites) and consolidating market; the repeal or judicial prohibition on implementation of the Affordable Care Act; changes in the health care industry; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global and domestic macroeconomic and political conditions, including inflation, deflation, recession, fluctuations in energy pricing and the value of the U.S.

可能导致实际结果与当前和历史结果产生重大差异的风险因素和不确定性包括但不限于：与新型冠状病毒及其任何变体相关的风险，以及其他疾病爆发，流行病，大流行或类似广泛传播的公共健康问题和其他自然灾害；我们依赖第三方制造和供应我们的产品；我们开发或获取、维护和保护新产品（特别是技术产品）和技术的能力，这些产品和技术以可接受的利润率获得市场认可；与收购、处置和合资企业相关的过渡性挑战，包括未能实现预期的协同效应/收益；与收购、处置和合资企业相关的法律、监管、合规、网络安全、财务和税务风险；管理文件中的某些规定可能会阻碍第三方收购我们；供应商回扣或其他采购激励的不利变化；与企业品牌产品销售相关的风险；高度竞争（包括但不限于来自第三方在线商务网站的竞争）和巩固市场的影响；废除或司法禁止实施《平价医疗法案》；；客户购买力扩张和多层成本结构带来的风险；我们的产品的运输成本增加或与我们的第三方托运人的其他服务问题；全球和国内总体宏观经济和政治状况，包括通货膨胀、通货紧缩、衰退、能源价格波动和美国的价值。

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements except as required by law..

我们警告说，这些因素可能并不详尽，其中许多因素超出了我们的控制或预测能力。。除法律要求外，我们没有义务更新前瞻性声明。